Fundraising Fox

Glucose Health

OTC: GLUC

Bentonville, US · Delaware corporation

Founders & leadership

FF
Fleming FlemingExecutive
MS
Mark SchaftleinCEO and Director of Issuer
MH
Marc HatchExecutive
MF
Murray FlemingNamed on SEC filing

Board

EB
Edmund BurkeBoard director
CJ
Chris JemapeteBoard director

Reported raises · per SEC filings

Form D private placements

$2.3M disclosed across 8 rounds · 2019–2026

$60KraisedJul 2026 · 1 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark SchaftleinDirector
  • Marc HatchExecutive Officer
  • Chris JemapeteDirector
  • Edmund BurkeDirector
Offering amount
$120K
Amount sold
$60K
Minimum investment
$60K
First sale
Jun 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$100KraisedFeb 2026 · 1 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • Marc HatchExecutive Officer
  • Mark SchaftleinExecutive Officer, Director
  • Chris JemapeteDirector
  • Edmunc burkeDirector
Offering amount
$100K
Amount sold
$100K
Minimum investment
$100K
First sale
Jan 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$20KraisedDec 2025 · 2 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • Edmund BurkeDirector
  • Fleming FlemingDirector
  • Chris JemapeteDirector
  • Mark SchaftleinExecutive Officer, Director
  • Marc HatchExecutive Officer
Offering amount
$20K
Amount sold
$20K
Minimum investment
$10K
First sale
Nov 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$290KraisedJan 2024 · 5 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • Murray FlemingExecutive Officer, Director
Offering amount
$290K
Amount sold
$290K
Minimum investment
$15K
First sale
Dec 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$960KraisedMar 2021 · 10 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • Murray FlemingExecutive Officer, Director
  • Hal KravitzDirector
  • Gerry DavidDirector
  • John FieldlyDirector
Offering amount
$960K
Amount sold
$960K
Minimum investment
$25K
First sale
Feb 2021
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$300KraisedJun 2020 · 8 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • Hal KravitzDirector
  • Gerry DavidDirector
  • John FieldlyDirector
  • Murray FlemingExecutive Officer, Director
Offering amount
$300K
Amount sold
$300K
First sale
Jun 2020
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$65KraisedMay 2020 · 4 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • Murray FlemingExecutive Officer
Offering amount
$65K
Amount sold
$65K
First sale
May 2020
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$460KraisedMay 2019 · 4 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • Murray FlemingExecutive Officer
Offering amount
$460K
Amount sold
$460K
First sale
May 2019
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Frequently asked questions

How much funding has Glucose Health raised?
Glucose Health has disclosed $2.3M raised across 8 rounds.
Where is Glucose Health headquartered?
Glucose Health is headquartered in Bentonville, US.